Goldman Sachs Analyst Sees 60% Upside In Uber, 28% In Lyft

Goldman Sachs analyst Eric Sheridan initiated coverage of the U.S. internet sector with a "selectively positive view." 
  • Goldman Sachs analyst Eric Sheridan initiated coverage of the U.S. internet sector with a “selectively positive view.” 
  • Sheridan rated Uber Technologies (NYSE:UBER) with a Buy and $64 price target, implying a 60.4% upside.
  • Sheridan also initiated coverage on Lyft Inc (NASDAQ:LYFT), with a Buy and $64 price target, suggesting a 28% upside.
  • The analyst initiated coverage of Facebook Inc (NASDAQ:FB) with a Buy rating and $455 price target, signifying a 20.2% upside.
  • Sheridan initiated coverage of Snap Inc (NYSE:SNAP) with a Buy rating and $90 price target, suggesting a 20.8% upside.
  • Sheridan initiated coverage of Pinterest (NYSE:PINS) with a Neutral rating and $57 price target, implying a 5.1% upside.
  • Sheridan noted that the industry still has “ample opportunities” for secular revenue growth and increased operating efficiencies on the back of building scale in the coming years. 
  • The analyst sees Uber as the “next large-cap platform ecosystem” in his coverage universe, given its user and economic capture scale around a common theme of local transportation and e-commerce.
  • Price Action: LYFT shares traded higher by 3.44% at $51.73, and UBER shares traded higher by 2.12% at $40.74 in the market session on the last check Monday.
Total
0
Shares
Related Posts
Read More

Novavax Says Phase 1/2 Clinical Trial Of Covid-19-influenza Combination Vaccine Candidate Indicates Vaccine Is Well-Tolerated And Immunogenic; Says Data From Covid-19-influenza Combination Trial Will Inform Planned Phase 2 Dose Confirmation Trial

Initial Results from Novavax' COVID-19-Influenza Vaccine Trial are First to Show Feasibility of Combination Vaccine Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic

NVAX